同仁堂国药获批在香港销售“金钵石斛散【同仁堂】”

财中社
20 Mar

  3月20日,同仁堂国药(03613)发布公告,公司近日获得香港中医药管理委员会颁发的《中成药注册证明书》,准许将“金钵石斛散【同仁堂】”在香港特别行政区出售。

  该药品的注册编号为HKC-18754,有效期限至2030年1月23日。公司在“金钵石斛散【同仁堂】”的研发投入累计约200万港元,尚未投入市场销售。

  此次获得注册证明书将有助于丰富公司的产品线,并推动市场拓展。

(文章来源:财中社)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10